ONCO · Oncopeptides AB · Insider Trading
Market Cap
953.39M SEK
Shares
381.36M
Transactions in Oncopeptides AB securities by directors, senior managers and their closely associated persons, as published by the market regulator under the EU Market Abuse Regulation.
Director and related-person transactions
Source-reported director and related-person transactions, including amendments and historical rows. Not a complete insider-ownership register. Coverage is limited to captured publication days; gaps may exist between the first and last day. A verified issuer LEI includes other instruments of that issuer; an ISIN-only match covers that security. Instrument types and transaction descriptions are retained verbatim; do not sum revised, historical or derivative rows as share purchases. Publication timestamps are local source times.
| Transaction date | Person | Transaction | Instrument | Volume | Price | Status |
|---|---|---|---|---|---|---|
| 2026-06-09 | Christine Elizabeth Rankin Member of the Board of Directors · Related person: | Allotment | Oncopeptides AB Share · SE0009414576 | 59897 Quantity | 0 SEK | Current |
| 2026-06-09 | Per Wold-Olsen Chairman of the Board of Directors · Related person: | Allotment | Ordinary Share (ONCO) Share · SE0009414576 | 149743 Quantity | 0 SEK | Current |
| 2026-03-19 | Stefan Norin Other member of the company's administrative, management or supervisory body · Related person: | Allotment | Oncopeptides Share · SE0009414576 | 3000 Quantity | 1.55 SEK | Current |
| 2026-03-17 | Christine Elizabeth Rankin Member of the Board of Directors · Related person: | Acquisition | Oncopeptides AB Share · SE0009414576 | 14631 Quantity | 1.625 SEK | Current |
| 2026-03-17 | Per Wold-Olsen Chairman of the Board of Directors · Related person: | Subscription | Oncopeptides BTA BTA · SE0021924370 | 418876 Quantity | 1.55 SEK | Current |
| 2026-03-17 | Sofia Heigis Chief Executive Officer (CEO)/Managing Directory · Related person: | Subscription | Oncopeptides BTA BTA · SE0027999608 | 87833 Quantity | 1.55 SEK | Current |
| 2026-03-17 | David Augustsson Other member of the company's administrative, management or supervisory body · Related person: | Acquisition | Oncopeptides BTA BTA · SE0027999608 | 1070 Quantity | 1.53 SEK | Current |
| 2026-03-17 | David Augustsson Other member of the company's administrative, management or supervisory body · Related person: | Acquisition | Oncopeptides BTA BTA · SE0027999608 | 4681 Quantity | 1.53 SEK | Current |
| 2026-03-17 | David Augustsson Other member of the company's administrative, management or supervisory body · Related person: | Acquisition | Oncopeptides BTA BTA · SE0027999608 | 6756 Quantity | 1.53 SEK | Current |
| 2026-03-17 | David Augustsson Other member of the company's administrative, management or supervisory body · Related person: | Acquisition | Oncopeptides BTA BTA · SE0027999608 | 1872 Quantity | 1.53 SEK | Current |
| 2026-03-16 | Eva Sabina Marianne Nordström Deputy CEO/Deputy Managing Director · Related person: | Subscription | ONCO BTA BTA · SE0027999608 | 140232 Quantity | 1.55 SEK | Current |
| 2026-03-16 | David Augustsson Other member of the company's administrative, management or supervisory body · Related person: | Allotment | Oncopeptides BTA BTA · SE0027999608 | 456 Quantity | 1.55 SEK | Current |
| 2026-03-16 | David Augustsson Other member of the company's administrative, management or supervisory body · Related person: | Allotment | Oncopeptides BTA BTA · SE0027999608 | 66 Quantity | 1.55 SEK | Current |
| 2026-03-16 | Henrik Bergentoft Chief Financial Officer (CFO) · Related person: | Subscription | Oncopeptides AB BTA BTA · SE0027999608 | 14258 Quantity | 1.55 SEK | Current |
| 2026-03-16 | Stefan Norin Other member of the company's administrative, management or supervisory body · Related person: | Subscription | Oncopeptides BTA BTA · SE0027999608 | 6266 Quantity | 1.55 SEK | Current |
| 2025-10-17 | Per Wold-Olsen Chairman of the Board of Directors · Related person: | Allotment | Ordinary share (ONCO) Share · SE0009414576 | 254311 Quantity | 0 SEK | Current |
| 2025-09-17 | Stefan Norin Other member of the company's administrative, management or supervisory body · Related person: | Allotment | Oncopeptides Share · SE0009414576 | 723 Quantity | 3.2 SEK | Current |
| 2025-09-17 | Per Wold-Olsen Chairman of the Board of Directors · Related person: | Subscription | Oncopeptides BTA BTA · SE0021924370 | 146362 Quantity | 3.2 SEK | Current |
| 2025-09-16 | Per Wold-Olsen Chairman of the Board of Directors · Related person: | Subscription | BTA BTA · SE0021924370 | 79590 Quantity | 3.2 SEK | Current |
| 2025-09-16 | Henrik Bergentoft Chief Financial Officer (CFO) · Related person: | Subscription | BTA BTA · SE0026141947 | 5184 Quantity | 3.2 SEK | Current |
| 2025-09-15 | David Augustsson Other member of the company's administrative, management or supervisory body · Related person: | Subscription | Oncopeptides AB BTA BTA · SE0026141947 | 222 Quantity | 3.2 SEK | Current |
| 2025-09-15 | David Augustsson Other member of the company's administrative, management or supervisory body · Related person: | Subscription | Oncopeptides AB BTA BTA · SE0026141947 | 4628 Quantity | 3.2 SEK | Current |
| 2025-09-15 | Sofia Heigis Chief Executive Officer (CEO)/Managing Directory · Related person: | Subscription | Oncopeptides AB BTA BTA · SE0026141947 | 12626 Quantity | 3.2 SEK | Current |
| 2025-09-15 | Sofia Heigis Chief Executive Officer (CEO)/Managing Directory · Related person: | Subscription | Oncopeptides AB BTA BTA · SE0026141947 | 19312 Quantity | 3.2 SEK | Current |
| 2025-09-15 | Christine Elizabeth Rankin Member of the Board of Directors · Related person: | Subscription | Aktie BTA · SE0009414576 | 5320 Quantity | 3.2 SEK | Current |
| 2025-09-15 | Stefan Norin Other member of the company's administrative, management or supervisory body · Related person: | Subscription | Oncopeptides BTA BTA · SE0026141947 | 2146 Quantity | 3.2 SEK | Current |
| 2025-08-26 | David Augustsson Other member of the company's administrative, management or supervisory body · Related person: | Acquisition | Oncopeptides AB Share · SE0009414576 | 1000 Quantity | 4.77 SEK | Current |
| 2025-08-26 | David Augustsson Other member of the company's administrative, management or supervisory body · Related person: | Acquisition | Oncopeptides AB Share · SE0009414576 | 1000 Quantity | 4.775 SEK | Current |
| 2025-08-26 | Sofia Heigis Chief Executive Officer (CEO)/Managing Directory · Related person: | Acquisition | Oncopeptides AB Share · SE0009414576 | 56820 Quantity | 4.4 SEK | Current |
| 2025-08-25 | David Augustsson Other member of the company's administrative, management or supervisory body · Related person: | Acquisition | Oncopeptides AB Share · SE0009414576 | 3500 Quantity | 4.38 SEK | Current |
| 2024-06-28 | Ulf Jungnelius Member of the Board of Directors · Related person: | Allotment | Oncopeptides AB Share · SE0009414576 | 43292 Quantity | 0 SEK | Current |
| 2024-06-28 | Per Wold-Olsen Chairman of the Board of Directors · Related person: | Allotment | Oncopeptides AB Share · SE0009414576 | 108231 Quantity | 0 SEK | Current |
| 2024-06-27 | Cecilia Daun Wennborg Member of the Board of Directors · Related person: | Allotment | Share Share · SE0009414576 | 43292 Quantity | 0 SEK | Current |
| 2024-05-07 | Stefan Norin Other member of the company's administrative, management or supervisory body · Related person: | Acquisition | Oncopeptides AB Allocation Share · SE0009414576 | 5000 Quantity | 2.6 SEK | Current Korrigering av stavfel (Namn på emittent) |
| 2024-05-07 | Stefan Norin Other member of the company's administrative, management or supervisory body · Related person: | Acquisition | Oncopeptides AB Allocation Share · SE0009414576 | 5000 Quantity | 2.6 SEK | Revised |
| 2024-05-03 | Stig Anders Jacob Lindberg Other senior executive · Related person: | Subscription | Oncopeptides AB BTA BTA · SE0021924370 | 1090708 Quantity | 2.6 SEK | Current |
| 2024-05-03 | Per Wold-Olsen Chairman of the Board of Directors · Related person: | Subscription | Oncopeptides BTA BTA · SE0021924370 | 519180 Quantity | 2.6 SEK | Current |
| 2024-05-03 | Sofia Heigis Chief Executive Officer (CEO)/Managing Directory · Related person: | Subscription | Oncopeptides AB BTA BTA · SE0021924370 | 66804 Quantity | 2.6 SEK | Current Ändrat karaktär från förvärv till teckning |
| 2024-05-03 | David Augustsson Other member of the company's administrative, management or supervisory body · Related person: | Subscription | Oncopeptides BTA BTA · SE0021924370 | 9332 Quantity | 2.6 SEK | Current |
| 2024-05-03 | Henrik Bergentoft Chief Financial Officer (CFO) · Related person: | Subscription | Oncopeptides BTA BTA · SE0021924370 | 13332 Quantity | 2.6 SEK | Current |
| 2024-05-03 | Sofia Heigis Chief Executive Officer (CEO)/Managing Directory · Related person: | Acquisition | Oncopeptides AB BTA BTA · SE0021924370 | 66804 Quantity | 2.6 SEK | Revised |
| 2024-05-03 | Cecilia Daun Wennborg Member of the Board of Directors · Related person: | Subscription | Oncopeptides AB BTA BTA · SE0021924370 | 15732 Quantity | 2.6 SEK | Current |
| 2024-05-03 | Stefan Norin Other member of the company's administrative, management or supervisory body · Related person: | Subscription | Oncopeptides AB BTA BTA · SE0021924370 | 2664 Quantity | 2.6 SEK | Current |
| 2024-05-03 | Eva Sabina Marianne Nordström Deputy CEO/Deputy Managing Director · Related person: | Subscription | Oncopeptides AB BTA BTA · SE0021924370 | 160264 Quantity | 2.6 SEK | Current |
| 2024-04-29 | Sofia Heigis Chief Executive Officer (CEO)/Managing Directory · Related person: | Acquisition | Oncopeptides AB TR Subscription right/Unit right · SE0021924362 | 30000 Quantity | 0.0366 SEK | Current Ändrad pris per enhet och transaktionsdatum då föregående order ej gick igenom |
| 2024-04-25 | Sofia Heigis Chief Executive Officer (CEO)/Managing Directory · Related person: | Acquisition | Oncopeptides AB TR Subscription right/Unit right · SE0021924362 | 30000 Quantity | 0.137 SEK | Revised |
| 2024-04-19 | Per Wold-Olsen Chairman of the Board of Directors · Related person: | Subscription | ONCO BTA BTA · SE0021924370 | 204664 Quantity | 2.6 SEK | Cancelled Per Wold exercised his subsription rights in the ongoing rights issue, understanding BTA:s was in in his account. Those has however not arrived yet, reporting will take plaece on BTA:s are received |
| 2024-04-19 | Per Wold-Olsen Chairman of the Board of Directors · Related person: | Subscription | ONCO BTA BTA · SE0021924370 | 204664 Quantity | 2.6 SEK | Cancelled Rättad ISIN kod samt transaktionens karkatär |
| 2024-04-19 | Per Wold-Olsen Chairman of the Board of Directors · Related person: | Acquisition | ONCO BTA BTA · SE0021924370 | 204664 Quantity | 2.6 SEK | Cancelled Rättad ISIN kod |
| 2024-04-19 | Per Wold-Olsen Chairman of the Board of Directors · Related person: | Acquisition | ONCO BTA BTA · SE0009414576 | 204664 Quantity | 2.6 SEK | Cancelled |
3747 publication days captured; dates between 2016-07-03 and 2026-10-07 may contain gaps. Checked 2026-10-08 10:44 UTC.
Showing 1–50 of 185 transactions